News

PATH/Gabe Bienczycki
WHO Member States Must Increase Investments in R&D for New Tools to Meet Urgent Health Challenges

Next week’s World Health Assembly will be setting priorities that have enormous life-altering implications for billions of people around the world. The Global Health Technologies Coalition (GHTC) is calling on World Health Organization (WHO) member states to increase investments in research and development (R&D), as new tools and technologies are essential for meeting urgent challenges, from achieving universal health coverage (UHC) to fighting antimicrobial resistance (AMR), including drug-resistant tuberculosis (DR-TB), and emerging threats like Ebola.

Learn More

United States Mission Geneva
GHTC director quoted in Global Health Now article highlighting issues to watch at WHA

GHTC Director Jamie Bay Nishi was quoted in a Global Health Now article previewing the issues to watch at the 72nd World Health Assembly.

View

PATH/Matthew Dakin
GHTC signs letters urging continued support for defense health research programs

GHTC endorsed letters to House and Senate appropriators from the Defense Health Research Consortium urging continued support for defense health research programs funded through the Congressionally Directed Medical Research Programs in the fiscal year 2020 budget.

PDF

PATH/Ruhani Kaur
GHTC delivers statement on access to medicines at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session encouraging the US delegation to support a comprehensive approach to addressing barriers to accessing essential technologies. GHTC welcomed ongoing efforts by the World Health Organization (WHO) to strengthen regulatory systems to accelerate access and urged the US delegation to support the expansion of WHO’s Essential Diagnostic list.

Learn More

CDC/James Gathany
GHTC delivers statement on AMR at HHS WHA listening session

GHTC delivered a statement at the US Department of Health and Human Services (HHS) World Health Assembly (WHA) Stakeholder Listening Session welcoming the US government’s commitment and collaborative action, with the World Health Organization and other stakeholders, to advance development of new antimicrobials, vaccines, and diagnostics to combat antimicrobial resistance (AMR). GHTC urged the US delegation and other member states to increase investment in R&D to combat AMR and to support enhanced cooperation at all levels to tackle this growing challenge.

Learn More

All News

Announcements

Breakthroughs Blog

GHTC in the Media

Advocacy Actions

Our members work to improve health worldwide